157 related articles for article (PubMed ID: 37924452)
1. Genetic polymorphisms in VEGFA and VEGFR2 genes associated with coronary heart disease susceptibility and severity.
Hajer F; Hana S; Saoussen C; Abdelhak F; Nadia B; Ameni D; Habib G; Hassen BA; Amel HK
Mol Biol Rep; 2023 Dec; 50(12):10169-10177. PubMed ID: 37924452
[TBL] [Abstract][Full Text] [Related]
2. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.
Liu D; Song J; Ji X; Liu Z; Cong M; Hu B
Medicine (Baltimore); 2016 May; 95(19):e3413. PubMed ID: 27175642
[TBL] [Abstract][Full Text] [Related]
3. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis.
Wang Y; Huang Q; Liu J; Wang Y; Zheng G; Lin L; Yu H; Tang W; Huang Z
Oncotarget; 2017 May; 8(18):30539-30551. PubMed ID: 28430629
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.
Kim DH; Xu W; Kamel-Reid S; Liu X; Jung CW; Kim S; Lipton JH
Ann Oncol; 2010 Jun; 21(6):1179-1188. PubMed ID: 19875757
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
[TBL] [Abstract][Full Text] [Related]
7. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract][Full Text] [Related]
8. VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.
Kim MK; Suh C; Chi HS; Cho HS; Bae YK; Lee KH; Lee GW; Kim IS; Eom HS; Kong SY; Bae SH; Ryoo HM; Shin IH; Mun YC; Chung H; Hyun MS
Cancer Sci; 2012 Mar; 103(3):497-503. PubMed ID: 22129133
[TBL] [Abstract][Full Text] [Related]
9. Missense Variants in Hypoxia-Induced VEGFA/VEGFR2 Signaling Predict the Outcome of Large Artery Atherosclerotic Stroke.
Li Z; Wang M; Gu J; Zhao L; Guo Y; Zhang Z; Liu X
Cell Mol Neurobiol; 2021 Aug; 41(6):1217-1225. PubMed ID: 32506171
[TBL] [Abstract][Full Text] [Related]
10. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
[TBL] [Abstract][Full Text] [Related]
11. Association of VEGF-A and KDR polymorphisms with the development of schizophrenia.
Saoud H; Aflouk Y; Ben Afia A; Gaha L; Bel Hadj Jrad B
Hum Immunol; 2022 Jun; 83(6):528-537. PubMed ID: 35428537
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
[TBL] [Abstract][Full Text] [Related]
13. Methionine sulfoxide reductase A rs10903323 G/A polymorphism is associated with increased risk of coronary artery disease in a Chinese population.
Gu H; Chen W; Yin J; Chen S; Zhang J; Gong J
Clin Biochem; 2013 Nov; 46(16-17):1668-72. PubMed ID: 23880405
[TBL] [Abstract][Full Text] [Related]
14. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.
Osadnik T; Strzelczyk JK; Lekston A; Reguła R; Bujak K; Fronczek M; Gawlita M; Gonera M; Wasilewski J; Szyguła-Jurkiewicz B; Gierlotka M; Gąsior M
BMC Cardiovasc Disord; 2016 Nov; 16(1):218. PubMed ID: 27835972
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor gene polymorphisms and coronary heart disease: a systematic review and meta-analysis.
Zhao X; Meng L; Jiang J; Wu X
Growth Factors; 2018 Aug; 36(3-4):153-163. PubMed ID: 30317903
[TBL] [Abstract][Full Text] [Related]
16. VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.
Kaddu-Mulindwa D; Rosolowski M; Ziepert M; Regitz E; Assmann G; Bewarder M; Held G; Pfreundschuh M; Bittenbring JT
Eur J Haematol; 2021 Jan; 106(1):100-104. PubMed ID: 32997825
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis.
Zhang Y; Qiu H; Zhang H; Wang L; Zhuang C; Liu R
Scand J Rheumatol; 2013; 42(5):344-8. PubMed ID: 23848209
[TBL] [Abstract][Full Text] [Related]
18. Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary heart disease susceptibility.
Han X; Liu L; Niu J; Yang J; Zhang Z; Zhang Z
Int J Clin Exp Pathol; 2015; 8(1):922-7. PubMed ID: 25755796
[TBL] [Abstract][Full Text] [Related]
19. Association of four CpG-SNPs in the vascular-related genes with coronary heart disease.
Xu L; Chen X; Ye H; Hong Q; Xu M; Duan S
Biomed Pharmacother; 2015 Mar; 70():80-3. PubMed ID: 25776483
[TBL] [Abstract][Full Text] [Related]
20. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
